Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations
Crossref DOI link: https://doi.org/10.1186/s43094-021-00231-5
Published Online: 2021-04-12
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
B, Ramya kuber
Addanki, Swetha
Text and Data Mining valid from 2021-04-12
Version of Record valid from 2021-04-12
Article History
Received: 30 July 2020
Accepted: 17 March 2021
First Online: 12 April 2021
Declarations
:
: Not applicable.
: No competing interests to declare.